New Wearable Devices in the Medical and Diagnostic Sectors

Aug 30, 2016, 09:00 ET from FinancialBuzz.com

NEW YORK, August 30, 2016 /PRNewswire/ --

A new segment of the wearable devices market is emerging and it is with a focus on medical and diagnostic purposes. The diagnostic wearable medical devices are using technology to remotely monitor, control, and track individual's vital signs. According to a recent report by Researchmoz, the global diagnostic wearable medical devices market is set to grow at a CAGR of 14.01% during the period 2016-2020. Biotricity Inc. (OTCQB: BTCY), DexCom, Inc. (NASDAQ: DXCM), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL), Fitbit Inc. (NASDAQ: FIT).

The report explores the different types of devices that can be used as wearable medical devices, and the different types of data that can be monitored by them. These are autonomous, non-invasive devices that help assess specific blood pressure, body temperature, respiratory rate, glucose quantity, heart rate, and blood oxygen saturation. While most companies try to appeal to various segments of the wearable devices markets, some focus on medical devices alone. A relatively new start-up company, Biotricity Inc. (OTCQB: BTCY) is focusing on biometric monitoring solutions for medical, healthcare and consumer use.

Biotricity Inc. has two devices under development that will launch into the market later this year, Bioflux - a heart-rhythm monitoring device that connects to an industry leading ECG (Electrocardiogram) FDA cleared software component and Biolife - designed to provide health and lifestyle solutions by monitoring ECG, respiration rate, calories, temperature, physical activity and more.

DexCom, Inc. (NASDAQ: DXCM) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes.

In Europe, the German based company Siemens AG (ADR) (OTCMKTS: SIEGY) has produced several innovative products and software for the medical wearables sector. For example, Siemens developed a software that enables images from their Freestyle ultrasound unit to be projected on the Alphabet Inc. (NASDAQ: GOOGL) Glass display.

Developing apps for wearable devices that can then be used for medical purposes is an intriguing proposition. In 2014 Google Glass was used during a surgery removing a tumor from a patient's abdominal cavity. The surgeon used voice commands to view the patient's MRI scans and X-ray images during the operation, essentially making it hands free.

Fitbit Inc. (NASDAQ: FIT) fitness trackers have been successful until the company failed to innovate, and sales started to drop. Shares of the company are down about 50% year to date. The company's CEO, James Park, explained why he thinks why wearable medical devices should one of Fitbit's future devices. "We are learning that lack of consumer engagement is a critical missing element in many broad healthcare efforts such as population health and disease management," he said, "…Since our devices and services are already engaging, Fitbit has incredible opportunity to serve as the consumer healthcare engagement engine."

Playing a wider role in medical wearable devices is becoming a major priority for companies. Despite the impressive growth expectations for this segment, there are some challenges to deal with in the near term, like high costs and lack of insurance policies. These challenges however are expected to be resolved overtime and are normal to new technologies in the medical field.

For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com    

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com has signed a three month financial news pr services agreement for fifteen thousand dollars directly from biotricity inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting the high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof.  The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com agreed to a three month financial news pr services agreement for fifteen thousand restricted shares directly from the company and additional same amount at the end of the term. We do not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security.  FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print.  Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information:

Media Contact: Danny A., info@financialbuzz.com , +1-877-601-1879

SOURCE FinancialBuzz.com